Home › Stocks › RVPH › All Fund Holders
RVPH — REVIVA PHARMACEUTCLS HLDGS I · All Fund Holders
Funds holding (latest): 21 · Reported value held: $2.92M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 3.20M | $892.12K | 0.00% | Add |
| Millennium Management history | Q1 2026 | 793.95K | $579.34K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q1 2026 | 762.24K | $556.20K | 0.04% | New |
| Citadel Advisors history | Q4 2025 | 1.51M | $420.88K | 0.00% | Add |
| Marshall Wace history | Q1 2025 | 216.50K | $205.67K | 0.00% | New |
| BNY Mellon history | Q1 2023 | 15.05K | $63.05K | 0.00% | Add |
| Geode Capital Management history | Q1 2026 | 72.99K | $53.27K | 0.00% | Reduce |
| Goldman Sachs Group history | Q1 2023 | 12.24K | $51.27K | 0.00% | Reduce |
| Renaissance Technologies history | Q1 2026 | 43.00K | $31.38K | 0.00% | New |
| BlackRock Inc history | Q1 2026 | 18.58K | $13.56K | 0.00% | Reduce |
| Two Sigma Investments history | Q1 2026 | 10.71K | $7.82K | 0.00% | Reduce |
| AQR Capital Management history | Q4 2025 | 28.00K | $7.81K | 0.00% | Hold |
| Northern Trust Corp history | Q1 2026 | 10.47K | $7.64K | 0.00% | Reduce |
| Morgan Stanley history | Q1 2026 | 8.53K | $6.22K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2025 | 15.00K | $5.72K | 0.00% | Hold |
| Citigroup Inc history | Q4 2025 | 18.39K | $5.13K | 0.00% | New |
| UBS Group AG history | Q1 2026 | 5.27K | $3.85K | 0.00% | Reduce |
| Deutsche Bank AG history | Q3 2024 | 2.00K | $2.88K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q4 2025 | 4.75K | $1.32K | 0.00% | New |
| Bank of America Corp history | Q4 2025 | 915 | $256 | 0.00% | Add |
| Wells Fargo & Co history | Q1 2026 | 150 | $109 | 0.00% | Reduce |